These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38629861)

  • 1. Assessment of Glycemia Risk Index and Standard Continuous Glucose Monitoring Metrics in a Real-World Setting of Exercise in Adults With Type 1 Diabetes: A Post-Hoc Analysis of the Type 1 Diabetes and Exercise Initiative.
    Morrison D; Vogrin S; Zaharieva DP
    J Diabetes Sci Technol; 2024 Jul; 18(4):787-794. PubMed ID: 38629861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid Closed-Loop Versus Manual Insulin Delivery in Adults With Type 1 Diabetes: A Post Hoc Analysis Using the Glycemia Risk Index.
    Lee MH; Vogrin S; Jones TW; O'Neal DN
    J Diabetes Sci Technol; 2024 Jul; 18(4):764-770. PubMed ID: 38372246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Glycemia Risk Index with Time in Range for Assessing Glycemic Quality.
    Kim JY; Yoo JH; Kim JH
    Diabetes Technol Ther; 2023 Dec; 25(12):883-892. PubMed ID: 37668665
    [No Abstract]   [Full Text] [Related]  

  • 4. Associations between daily step count classifications and continuous glucose monitoring metrics in adults with type 1 diabetes: analysis of the Type 1 Diabetes Exercise Initiative (T1DEXI) cohort.
    Turner LV; Marak MC; Gal RL; Calhoun P; Li Z; Jacobs PG; Clements MA; Martin CK; Doyle FJ; Patton SR; Castle JR; Gillingham MB; Beck RW; Rickels MR; Riddell MC;
    Diabetologia; 2024 Jun; 67(6):1009-1022. PubMed ID: 38502241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lag Time Remains with Newer Real-Time Continuous Glucose Monitoring Technology During Aerobic Exercise in Adults Living with Type 1 Diabetes.
    Zaharieva DP; Turksoy K; McGaugh SM; Pooni R; Vienneau T; Ly T; Riddell MC
    Diabetes Technol Ther; 2019 Jun; 21(6):313-321. PubMed ID: 31059282
    [No Abstract]   [Full Text] [Related]  

  • 6. Study of Glycemic Variability in Well-controlled Type 2 Diabetic Patients Using Continuous Glucose Monitoring System.
    Swami V; Yadav SK; Saxena P; Sharma A; Dash CK; Gupta A
    J Assoc Physicians India; 2024 Jan; 72(1):18-21. PubMed ID: 38736069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings.
    Klonoff DC; Wang J; Rodbard D; Kohn MA; Li C; Liepmann D; Kerr D; Ahn D; Peters AL; Umpierrez GE; Seley JJ; Xu NY; Nguyen KT; Simonson G; Agus MSD; Al-Sofiani ME; Armaiz-Pena G; Bailey TS; Basu A; Battelino T; Bekele SY; Benhamou PY; Bequette BW; Blevins T; Breton MD; Castle JR; Chase JG; Chen KY; Choudhary P; Clements MA; Close KL; Cook CB; Danne T; Doyle FJ; Drincic A; Dungan KM; Edelman SV; Ejskjaer N; Espinoza JC; Fleming GA; Forlenza GP; Freckmann G; Galindo RJ; Gomez AM; Gutow HA; Heinemann L; Hirsch IB; Hoang TD; Hovorka R; Jendle JH; Ji L; Joshi SR; Joubert M; Koliwad SK; Lal RA; Lansang MC; Lee WA; Leelarathna L; Leiter LA; Lind M; Litchman ML; Mader JK; Mahoney KM; Mankovsky B; Masharani U; Mathioudakis NN; Mayorov A; Messler J; Miller JD; Mohan V; Nichols JH; Nørgaard K; O'Neal DN; Pasquel FJ; Philis-Tsimikas A; Pieber T; Phillip M; Polonsky WH; Pop-Busui R; Rayman G; Rhee EJ; Russell SJ; Shah VN; Sherr JL; Sode K; Spanakis EK; Wake DJ; Waki K; Wallia A; Weinberg ME; Wolpert H; Wright EE; Zilbermint M; Kovatchev B
    J Diabetes Sci Technol; 2023 Sep; 17(5):1226-1242. PubMed ID: 35348391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-World Continuous Glucose Monitoring Data from a Population with Type 1 Diabetes in South Korea: Nationwide Single-System Analysis.
    Kim JY; Jin SM; Andrade SB; Chen B; Kim JH
    Diabetes Technol Ther; 2024 Jun; 26(6):394-402. PubMed ID: 38277166
    [No Abstract]   [Full Text] [Related]  

  • 9. Factors associated with Glycemia Risk Index in a cohort of patients with type 1 Diabetes Mellitus and Latent Autoimmune Diabetes In Adults (LADA).
    Herranz-Antolín S; Cotón-Batres C; López-Virgos MC; Esteban-Monge V; Álvarez-de Frutos V; Torralba M
    Endocrine; 2024 Nov; 86(2):574-583. PubMed ID: 38844609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Glycemia Risk Index Predicts Performance of Diabetes Self-Management Habits in Youth With Type 1 Diabetes Mellitus.
    Panfil K; Vandervelden CA; Lockee B; Tallon EM; Williams DD; Lee JM
    J Diabetes Sci Technol; 2024 Jul; 18(4):779-786. PubMed ID: 38708581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation Between the Glycemia Risk Index and Longitudinal Hemoglobin A1c in Children and Young Adults With Type 1 Diabetes.
    Panfil K; Redel JM; Vandervelden CA; Lockee B; Kahkoska AR; Tallon EM; Williams DD; Clements MA
    J Diabetes Sci Technol; 2024 Jul; 18(4):771-778. PubMed ID: 38715286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of glucose variability on the assessment of the glycemia risk index (GRI) and classic glycemic metrics.
    Pérez-López P; Férnandez-Velasco P; Bahillo-Curieses P; de Luis D; Díaz-Soto G
    Endocrine; 2023 Dec; 82(3):560-568. PubMed ID: 37695452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between key continuous glucose monitoring-derived metrics and specific cognitive domains in patients with type 2 diabetes mellitus.
    Dong S; Wang L; Zhao C; Zhang R; Gao Z; Jiang L; Guo Y; Zhou H; Xu S
    BMC Neurol; 2023 May; 23(1):200. PubMed ID: 37210479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal Sampling Duration for Continuous Glucose Monitoring for the Estimation of Glycemia Risk Index.
    Shah VN; Sakamoto C; Pyle L
    Diabetes Technol Ther; 2023 Feb; 25(2):140-142. PubMed ID: 36399111
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypoglycemia and glycemic variability of people with type 1 diabetes with lower and higher physical activity loads in free-living conditions using continuous subcutaneous insulin infusion with predictive low-glucose suspend system.
    Montt-Blanchard D; Sánchez R; Dubois-Camacho K; Leppe J; Onetto MT
    BMJ Open Diabetes Res Care; 2023 Mar; 11(2):. PubMed ID: 36944432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent-scanned continuous glucose monitoring with low glucose alarms decreases hypoglycemia incidence in middle-aged adults with type 1 diabetes in real-life setting.
    Oriot P; Hermans MP
    J Diabetes Complications; 2023 Feb; 37(2):108385. PubMed ID: 36603333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous Glucose Monitoring Metrics for Pregnancies Complicated by Diabetes: Critical Appraisal of Current Evidence.
    Szmuilowicz ED; Barbour L; Brown FM; Durnwald C; Feig DS; O'Malley G; Polsky S; Aleppo G
    J Diabetes Sci Technol; 2024 Jul; 18(4):819-834. PubMed ID: 38606830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycemic Risk Index Profiles and Predictors Among Diverse Adults With Type 1 Diabetes.
    Hoogendoorn CJ; Hernandez R; Schneider S; Harmel M; Pham LT; Crespo-Ramos G; Agarwal S; Crandall J; Peters AL; Spruijt-Metz D; Gonzalez JS; Pyatak EA
    J Diabetes Sci Technol; 2024 Sep; 18(5):1070-1078. PubMed ID: 36999215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycemia Risk Index as a Novel Metric to Evaluate the Safety of Glycemic Control in Children and Adolescents with Type 1 Diabetes: An Observational, Multicenter, Real-Life Cohort Study.
    Piona C; Marigliano M; Roncarà C; Mozzillo E; Di Candia F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Piccinno E; Delvecchio M; Passanisi S; Lombardo F; Bonfanti R; Maffeis C
    Diabetes Technol Ther; 2023 Jul; 25(7):507-512. PubMed ID: 37155332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limitations of 14-Day Continuous Glucose Monitoring Sampling for Assessment of Hypoglycemia and Glycemic Variability in Type 1 Diabetes.
    Akturk HK
    Diabetes Technol Ther; 2024 Jul; 26(7):503-508. PubMed ID: 38300516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.